U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864338) titled 'Pilot Study for Colorectal Cancer and Advanced Adenoma Detection with the Mainz Biomed Colorectal Cancer Test' on March 03.
Brief Summary: The Mainz Biomed Colorectal Cancer Screening Test is being studied for its performance in the identification of the presence of colorectal cancer (CRC) or advanced adenoma (AA) in the colon in patients at average risk for colorectal cancer.
Study Start Date: Dec. 18, 2022
Study Type: OBSERVATIONAL
Condition:
Colorectal Cancer Screening
Colorectal Cancer Metastatic
Colon Adenocarcinoma
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Mainz Biomed
Disclaimer: Curated by HT Syndication....